**About the Special Issue Editors**

**Ritva Tikkanen** is Professor of Biochemistry and Molecular Biology at the Medical Faculty of the University of Giessen, Germany. The main focus of her research is rare diseases, including lysosomal storage disorders, metabolic diseases, and autoimmune diseases. Her laboratory is specialized in developing personalized therapies for genetic diseases such as aspartylglucosaminuria, SSADH deficiency, and neuronal ceroid lipofuscinoses. In addition, she is interested in the regulation of MAP kinase signaling in cancer cells and in autoimmune diseases.

**David Nikolic-Paterson** is a basic scientist with degrees in Biochemistry and in Cellular Immunology. He is Head of Laboratory Research in the Department of Nephrology at Monash Medical Centre in Melbourne, Australia. Dr. Nikolic-Paterson's research focuses on mechanisms of inflammation and fibrosis in acute and chronic kidney disease and kidney transplant rejection, with a particular interest in the contribution of mitogen-activated protein kinase signaling pathways in disease pathogenesis.
